Chief Development Officer · Korro Bio, Inc. (KRRO)

Carl LeBel

A named executive officer of Korro Bio in every fiscal year CompBrief holds from FY2018 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$2,750,743

Salary $461,869Stock awards $286,200

FY2019: $2,217,219

3rd of 3 named executive officers at Korro Bio by FY2021 total.

3 named officers on file for Korro Bio, FY2021

Carl LeBel’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Korro Bio’s whole pay program stands against its peers

  • Korro Bio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on KRRO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2022 (DEF 14A).

Free

Get Carl LeBel’s full pay file as a PDF — free

More than this page: up to 10 years of Carl’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Carl LeBel compensation by year

Korro Bio Summary Compensation Table · all 3 fiscal years held
In US dollars, as Korro Bio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2021
Salary$268,542$370,417$461,869
Bonus$5,000$0$0
Stock awards$0$0$286,200
Option awards$57,377$1,605,602$1,831,138
Non-equity incentive$97,500$230,000$157,035
Pension and deferred compensation$0$0$0
All other$49,302$11,200$14,500
Total$477,721$2,217,219$2,750,743

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Korro Bio, Inc. DEF 14A filed April 29, 2022, accession 0001193125-22-133971, and prior-year filings.

How this page was built: the Korro Bio, Inc. filed document, accession 0001193125-22-133971. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.

$478K
$2.2M
$2.8M
FY18
FY19
FY21
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU30,000$153,900—
Option57,813—$35.85
Option27,607—$3.37
Option5,568—$0.61
Option29,949—$25.05
Option82,013—$14.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Korro Bio, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Korro Bio’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
David LucchinoPresident and Chief Executive Officer$5,821,532
Quentin McCubbinChief Manufacturing Officer$3,303,416
Carl LeBel · this pageChief Development Officer$2,750,743

The full Korro Bio compensation record

free company brief

This page is one person within Korro Bio's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Korro Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Carl LeBel's compensation dossier · One-time report. No refunds.